Subscribe to RSS
DOI: 10.1055/s-0042-1750823
Venture of a Tertiary Care Neurosurgical Center in Course of COVID-19 Lockdown without RT-PCR
Abstract
“I will not permit considerations of age, disease or disability, creed, ethnic origin, gender, nationality, political affiliation, race, sexual orientation, social standing or any other factor to intervene between my duty and my patient.” Obliged by the aforementioned oath, no medical practitioner shall sit in a moral judgment on any patient but will treat their illness to the best of their ability whatever the circumstances. A clear concord was yet to be authorized after the World Health Organization (WHO) declared the global pandemic of severe acute respiratory syndrome coronavirus 2infection. As a diagnostic modality, WHO recommended real-time reverse transcription–polymerase chain reaction (RT-PCR) as a reliable test; however, its availability in a deprived nation like ours became a major restraining factor. Despite an asset of having high specificity, RT-PCR for coronavirus disease 2019has its own liability of having low sensitivity. Henceforth, as time passed by, the validity of the rapid diagnostic tests was put into question. In later months, a few centers around our periphery started conducting RT-PCR, but the time taken to obtain the result was long-drawn-out process and the patient who needed urgent neurosurgical intervention at Annapurna Neurological Institute and Allied Sciences had to wait. We would like to share our expedition through peaks and valleys of managing 215 patients during the vicious circle of lockdown and global pandemic.
Publication History
Article published online:
01 September 2022
© 2022. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Shrestha R, Shrestha S, Khanal P, KC B. Nepal's first case of COVID-19 and public health response. J Travel Med 2020; 27 (03) taaa024
- 2 Rayamajhee B, Pokhrel A, Syangtan G. et al. How well the government of Nepal is responding to COVID-19? An experience from a resource-limited country to confront unprecedented pandemic. Front Public Health 2021; 9: 597808
- 3 Iniesta I. Hippocratic corpus. BMJ 2011; 342 (02) 688
- 4 Suicide cases on the rise in Nepal during COVID-19 lockdown- The New Indian Express. 2020
- 5 Advice on the use of point-of-care immunodiagnostic tests for COVID-19 [Internet]. [cited 2021 May 27]. Accessed April 25, 2022 at: https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19
- 6 Coronavirus disease (COVID-19) outbreak updates & resource materials – Health Emergency Operation Center [Internet]. [cited 2021 May 27]. Accessed April 25, 2022 at: https://heoc.mohp.gov.np/update-on-novel-corona-virus-covid-19/
- 7 Singh DR, Sunuwar DR, Adhikari B, Szabo S, Padmadas SS. The perils of COVID-19 in Nepal: implications for population health and nutritional status. J Glob Health 2020; 10 (01) 010378